Organofluorides
Search Within Results
1
–
2
of
2
results
1
Medchemexpress LLC GSK256066 Trifluoroacetate | 1415560-64-3 | 99.8% | C29H27F3N4O7S | 1 ML
GSK256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. It is developed for the research of chronic obstructive pulmonary disease.
- Selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor
- IC50 of 3.2 pM for PDE4B
- Designed for inhaled administration
- Highly selective for PDE4
- Inhibits PDE4 isoforms A-D with equal affinity
- Inhibits tumor necrosis factor alpha production by lipopolysaccharide (LPS)-stimulated human peripheral blood monocytes
- Inhibits eosinophil number in bronchoalveolar lavage in animal models
- Inhibits LPS-induced pulmonary neutrophilia
2
Medchemexpress LLC GSK256066 trifluoroacetate | 1415560-64-3 | 99.8% | 632.61 g·mol⁻¹ | C29H27F3N4O7S | 10 MG
The trifluoroacetate salt of GSK256066 is a selective, high-affinity phosphodiesterase 4 (PDE4) inhibitor used in preclinical research on respiratory inflammatory diseases such as COPD. It displays picomolar potency against PDE4B and suppresses LPS-induced tumor necrosis factor α production in human monocytes.
- High affinity for PDE4B (IC50 ≈ 3.2 pM)
- Inhibits LPS-stimulated TNFα production (IC50 ≈ 0.01 nM)
- High selectivity versus other PDE families
- Supplied as a trifluoroacetate salt for improved handling
- Available in small research pack sizes suitable for assay development